Atmus Filtration Technologies Inc. — Form 8-K Summary
Reporting date: August 3, 2023; the report was signed August 7, 2023. The filing addresses accounting errors in financial statements included in the company’s IPO registration statement and related periods.
Business Context and Reporting Period
Atmus completed its initial public offering and partial separation from Cummins Inc. in May 2023. The Audit Committee concluded that the condensed combined financial statements for the three months ended March 31, 2023 should no longer be relied upon. Comparative periods, including March 31, 2022 and fiscal years 2020 through 2022, will also be revised.
Financial Impact and Key Metrics
- Cash provided by operating activities for the three months ended March 31, 2023 was overstated by approximately $15.1 million, or 22.4%, due principally to errors involving related party receivables, related party payables, and net parent investment.
- Including other errors originally considered immaterial, the total overstatement of cash provided by operating activities was $24.7 million.
- The cash flow overstatement was offset by an overstatement of cash used in investing activities of $2.8 million and cash used in financing activities of $21.9 million.
- The errors did not affect reported revenue, net income, or EBITDA for the three months ended March 31, 2023.
- The errors did not affect the company’s cash balance upon its initial public offering.
- The filing does not provide revised revenue, profit, margin, debt, or liquidity figures in the supplied text.
Material Changes and Accounting Issues
The errors were identified while preparing financial statements for the three and six months ended June 30, 2023. They primarily resulted from an incomplete manual adjustment used to eliminate intercompany and related party transactions.
Atmus will restate or revise the affected interim and annual financial statements, related management’s discussion and analysis, and risk factor disclosures. The company identified a material weakness in internal control over financial reporting because controls over period-end reporting did not completely identify and accurately account for intercompany and related party transactions.
Outlook, Remediation, and Risks
- Management, with Audit Committee oversight, has begun remediation efforts, but the filing does not state when the material weakness will be fully remediated.
- Management concluded that disclosure controls and procedures were not effective as of March 31, 2023 and December 31, 2022.
- Potential risks include legal or regulatory proceedings related to the restatement, adverse effects on the company’s business, results of operations, financial condition, and stock price, and additional effects from the correction process.
- Restated and revised financial statements, updated MD&A, and updated risk factors are included in Exhibits 99.1 and 99.2. Exhibit 99.3 contains PwC’s consent.
Investor Verification Items
- Verify the restated March 31, 2023 and revised March 31, 2022 financial statements in Exhibit 99.1.
- Review the revised annual financial statements for 2020, 2021, and 2022 in Exhibit 99.2.
- Confirm the final effects of the corrections on balance sheet accounts, cash-flow classifications, and comparative disclosures.
- Assess management’s remediation plan and any subsequent disclosure regarding the material weakness.
- Monitor for related legal, regulatory, audit, or market consequences and for any further restatements.